-
- Posted Thursday March 14, 2013
TGen findings highlighted at 7th annual cancer conference
Arizona Myeloma Network (AzMN) focuses on 'Living with Myeloma'
SCOTTSDALE, Ariz. - March 14, 2013 - The
Translational Genomics Research Institute (TGen) will present its
latest research about a cancer known as multiple myeloma at a free
public conference hosted by the Arizona Myeloma Network
(AzMN).
More than 300 people are expected at AzMN's 7th annual "Living
with Myeloma" conference, planned from 9 a.m.-4:30 p.m. Saturday,
March 23, at the Chaparral Suites Ballroom, 5001 N. Scottsdale
Road, Scottsdale, Ariz.
The conference is designed to provide patients, their families,
friends, caregivers, researchers, physicians and healthcare
professionals with cutting-edge information about the latest
research and the newest therapies for myeloma, which is a complex
and often misdiagnosed cancer of bone marrow plasma cells, which
attack and destroy bone.
TGen's Dr. Bodour Salhia, an Assistant Professor in TGen's
Integrated Cancer Genomics Division, will present her research,
looking into new approaches for targeting multiple myeloma.
Dr. Salhia's focus is on the affects of epigenetic changes -
heritable changes in DNA that do not affect an individual's DNA
sequence - and how those changes might play a role in affecting the
function of genes.
"I am thrilled to once again be presenting at AzMN's annual Living
with Myeloma conference," Dr. Salhia said. "I will be talking
specifically about the focus of research ongoing in my lab that
revolves around understanding the epigenetic changes underlying
multiple myeloma.
"My hope is to translate these findings into epigenetic therapies
for patients, especially in treatment resistant myeloma," Dr.
Salhia said. "I think this is a great venue to share some of the
latest in this research to the this patient-based audience."
In addition to TGen's Dr. Salhia, other nationally recognized
myeloma experts from Arizona and across the nation scheduled for
the conference are: Dr. Robert Kyle, Mayo Clinic, Rochester; Dr.
Joseph Mikhael, Mayo Clinic, Scottsdale; Dr. Jeffrey Schriber, Bone
Marrow Institute, Scottsdale Healthcare's Virginia G. Piper Cancer
Center.
"This year, our myeloma conference will focus on collaboration
among researchers, clinicians, and patient advocates in creating a
roadmap to a cure for myeloma," said Barbara Kavanagh, Founder and
President of the Arizona Myeloma Network. "This is a key
opportunity for patients and families to learn about this rare form
of blood cancer, and other cancers, to feel less alone, and find
hope for the future."
Registration is online at
http://www.azmyelomanetwork.org/what/2013confreg.html, or from 8-9
a.m. at the conference. Free continental breakfast and lunch will
be provided, and 5.75 Continuing Medical Education credits are
available to medical professionals.
# # #
About the Arizona Myeloma Network
Founded in 2004, the Arizona Myeloma Network (AzMN) is a 501(c)(3)
nonprofit charity organization that conducts outreach events and
education programs, with special consideration for the underserved
African-American, Asian-Pacific, Hispanic American and Native
American populations. Volunteers and donations are always welcomed.
For more information, visit: www.azmyelomanetwork.org.
Press Contact:
Barbara Kavanagh
623-388-6837
[email protected]
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. Research at
TGen is focused on helping patients with diseases such as cancer,
neurological disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the
genetic components of common and complex diseases. Working with
collaborators in the scientific and medical communities, TGen
believes it can make a substantial contribution to the efficiency
and effectiveness of the translational process. For more
information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
